An appeal was argued before the 8th Circuit Court of Appeals as to whether HT drugs used less than three years and developed ductal cancer in situ should be stayed, or put on hold and possibly dismissed in the HTLitigation. Has the 8th Circuit Court of Appeals mad a decision on this?